10th Dec 2015 11:51
RNS Number : 6618I
GlaxoSmithKline PLC
10 December 2015
GlaxoSmithKline plc
Board Committee changes
GlaxoSmithKline plc (the "Company") announces that Vindi Banga, Senior Independent Director designate and Independent Non-Executive Director, has been appointed a member of the Audit & Risk, Nominations and Remuneration Committees with effect from 1 January 2016.
V A Whyte
Company Secretary
10 December 2015
This information is provided by RNS
The company news service from the London Stock Exchange
Related Shares:
Glaxosmithkline